AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Bloomberg Surveillance
Bloomberg Surveillance TV: March 28, 2024
Mar 28, 2024
Guests Matthew Miskin, Steve Center, and Robert Davis discuss market dependency on a dovish Fed, EV production outlook, and Merck's new lung disease drug. Topics include managing market expectations, Powell's financial policy approach, electric vehicle transition challenges, competition in the auto industry, innovative drug approval for pulmonary arterial hypertension, and drug pricing in healthcare.
25:55
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Markets reliant on dovish Fed; Kia's EV outlook influenced by policy.
- Merck launches Winrever for lung disease; strategic move into cardiometabolic space.
Deep dives
Innovative Treatment for Pulmonary Arterial Hypertension
Merck has developed a groundbreaking biologic drug, Winrever, to address pulmonary arterial hypertension, a devastating disease with high mortality rates. This first-in-class medicine remodels blood vessels in the lungs to combat heart disease. Administered every three weeks via subcutaneous injection, it offers hope to patients and families affected by this rare condition.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode